| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 7.45e-07 | 1244 | 24 | 10 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 9.07e-07 | 1271 | 24 | 10 | GO:0000987 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 3.19e-06 | 1459 | 24 | 10 | GO:0000977 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 2.13e-05 | 1412 | 24 | 9 | GO:0000981 | |
| GeneOntologyMolecularFunction | miRNA binding | 2.55e-05 | 48 | 24 | 3 | GO:0035198 | |
| GeneOntologyMolecularFunction | regulatory RNA binding | 5.51e-05 | 62 | 24 | 3 | GO:0061980 | |
| GeneOntologyMolecularFunction | G-rich strand telomeric DNA binding | 7.56e-05 | 11 | 24 | 2 | GO:0098505 | |
| GeneOntologyMolecularFunction | single-stranded telomeric DNA binding | 1.07e-04 | 13 | 24 | 2 | GO:0043047 | |
| GeneOntologyMolecularFunction | sequence-specific single stranded DNA binding | 1.44e-04 | 15 | 24 | 2 | GO:0098847 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 3.05e-04 | 276 | 24 | 4 | GO:0003730 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 4.65e-04 | 560 | 24 | 5 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 4.89e-04 | 566 | 24 | 5 | GO:0001216 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 5.39e-04 | 134 | 24 | 3 | GO:0003697 | |
| GeneOntologyMolecularFunction | telomeric DNA binding | 1.05e-03 | 40 | 24 | 2 | GO:0042162 | |
| GeneOntologyMolecularFunction | molecular condensate scaffold activity | 1.16e-03 | 42 | 24 | 2 | GO:0140693 | |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 1.21e-03 | 43 | 24 | 2 | GO:0030280 | |
| GeneOntologyMolecularFunction | mRNA binding | 1.23e-03 | 694 | 24 | 5 | GO:0003729 | |
| GeneOntologyMolecularFunction | pre-mRNA binding | 2.67e-03 | 64 | 24 | 2 | GO:0036002 | |
| GeneOntologyMolecularFunction | structural molecule activity | 3.66e-03 | 891 | 24 | 5 | GO:0005198 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 6.43e-03 | 320 | 24 | 3 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 6.77e-03 | 326 | 24 | 3 | GO:0001217 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 7.80e-03 | 111 | 24 | 2 | GO:0003727 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.06e-02 | 130 | 24 | 2 | GO:0005200 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 2.79e-08 | 75 | 25 | 5 | GO:0045109 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 1.13e-07 | 99 | 25 | 5 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 1.19e-07 | 100 | 25 | 5 | GO:0045103 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 2.24e-05 | 1399 | 25 | 9 | GO:0045892 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 2.42e-05 | 1413 | 25 | 9 | GO:1902679 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | 5.72e-05 | 870 | 25 | 7 | GO:0030855 | |
| GeneOntologyBiologicalProcess | protein heterotetramerization | 1.67e-04 | 16 | 25 | 2 | GO:0051290 | |
| GeneOntologyBiologicalProcess | epithelium development | 2.35e-04 | 1469 | 25 | 8 | GO:0060429 | |
| GeneOntologyBiologicalProcess | peptide cross-linking | 4.86e-04 | 27 | 25 | 2 | GO:0018149 | |
| GeneOntologyCellularComponent | keratin filament | 5.11e-06 | 97 | 25 | 4 | GO:0045095 | |
| GeneOntologyCellularComponent | intermediate filament | 6.43e-06 | 227 | 25 | 5 | GO:0005882 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 1.31e-05 | 263 | 25 | 5 | GO:0045111 | |
| GeneOntologyCellularComponent | transcription regulator complex | 6.13e-04 | 596 | 25 | 5 | GO:0005667 | |
| GeneOntologyCellularComponent | postsynaptic cytosol | 1.32e-03 | 45 | 25 | 2 | GO:0099524 | |
| GeneOntologyCellularComponent | chromatin | 1.36e-03 | 1480 | 25 | 7 | GO:0000785 | |
| GeneOntologyCellularComponent | cornified envelope | 3.07e-03 | 69 | 25 | 2 | GO:0001533 | |
| GeneOntologyCellularComponent | cytosolic region | 3.15e-03 | 70 | 25 | 2 | GO:0099522 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 3.77e-03 | 899 | 25 | 5 | GO:0099513 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 5.96e-03 | 97 | 25 | 2 | GO:0071013 | |
| HumanPheno | Epidermal acanthosis | 1.04e-05 | 54 | 14 | 4 | HP:0025092 | |
| HumanPheno | Hypergranulosis | 2.47e-05 | 22 | 14 | 3 | HP:0025114 | |
| HumanPheno | Congenital bullous ichthyosiform erythroderma | 4.20e-05 | 4 | 14 | 2 | HP:0007475 | |
| HumanPheno | Hyperparakeratosis | 4.20e-05 | 4 | 14 | 2 | HP:0040009 | |
| HumanPheno | Abnormal epidermal morphology | 9.45e-05 | 94 | 14 | 4 | HP:0011124 | |
| HumanPheno | Knuckle pad | 1.95e-04 | 8 | 14 | 2 | HP:0032541 | |
| HumanPheno | Alobar holoprosencephaly | 2.50e-04 | 9 | 14 | 2 | HP:0006988 | |
| HumanPheno | Semilobar holoprosencephaly | 2.50e-04 | 9 | 14 | 2 | HP:0002507 | |
| HumanPheno | Conjunctival nodule | 3.80e-04 | 11 | 14 | 2 | HP:0009903 | |
| HumanPheno | Conjunctival hamartoma | 3.80e-04 | 11 | 14 | 2 | HP:0100780 | |
| HumanPheno | Epidermal hyperkeratosis | 3.80e-04 | 11 | 14 | 2 | HP:0007543 | |
| HumanPheno | Diffuse palmoplantar hyperkeratosis | 3.80e-04 | 11 | 14 | 2 | HP:0007447 | |
| MousePheno | perinatal lethality | DACH1 KRT1 SP8 KRT10 HNRNPA1L2 FUS ILF3 SIX3 MN1 ALK FUBP1 ZIC2 | 2.22e-08 | 1130 | 22 | 12 | MP:0002081 |
| MousePheno | perinatal lethality, complete penetrance | 4.09e-08 | 712 | 22 | 10 | MP:0011089 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | DACH1 SOX4 KRT1 SP8 KRT10 HNRNPA1L2 FUS ILF3 SIX3 MN1 FUBP1 ZIC2 | 8.13e-08 | 1269 | 22 | 12 | MP:0011111 |
| MousePheno | neonatal lethality | 1.58e-06 | 799 | 22 | 9 | MP:0002058 | |
| MousePheno | blistering | 6.70e-06 | 24 | 22 | 3 | MP:0001208 | |
| MousePheno | abnormal eating behavior | 2.62e-05 | 604 | 22 | 7 | MP:0001431 | |
| MousePheno | abnormal suckling behavior | 2.65e-05 | 113 | 22 | 4 | MP:0001436 | |
| MousePheno | acanthosis | 4.01e-05 | 43 | 22 | 3 | MP:0001874 | |
| MousePheno | epidermis stratum spinosum hyperplasia | 4.60e-05 | 45 | 22 | 3 | MP:0009611 | |
| MousePheno | abnormal consumption behavior | 6.45e-05 | 695 | 22 | 7 | MP:0002069 | |
| MousePheno | neonatal lethality, complete penetrance | 1.34e-04 | 534 | 22 | 6 | MP:0011087 | |
| MousePheno | abnormal epidermis stratum spinosum morphology | 1.39e-04 | 65 | 22 | 3 | MP:0001236 | |
| MousePheno | abnormal esophagus morphology | 1.45e-04 | 66 | 22 | 3 | MP:0000467 | |
| MousePheno | abnormal intercostal muscle morphology | 2.45e-04 | 15 | 22 | 2 | MP:0002280 | |
| MousePheno | increased CD8-positive, naive alpha-beta T cell number | 2.45e-04 | 15 | 22 | 2 | MP:0013436 | |
| MousePheno | small lymphoid organs | 2.45e-04 | 15 | 22 | 2 | MP:0000687 | |
| MousePheno | lymphoid hypoplasia | 2.45e-04 | 15 | 22 | 2 | MP:0002223 | |
| MousePheno | abnormal esophageal epithelium morphology | 3.17e-04 | 17 | 22 | 2 | MP:0000468 | |
| MousePheno | hyperkeratosis | 3.64e-04 | 90 | 22 | 3 | MP:0001242 | |
| MousePheno | abnormal digestive system morphology | 3.71e-04 | 1233 | 22 | 8 | MP:0000462 | |
| MousePheno | abnormal foot pad morphology | 7.51e-04 | 26 | 22 | 2 | MP:0000574 | |
| MousePheno | hyperpigmentation | 8.72e-04 | 28 | 22 | 2 | MP:0001188 | |
| MousePheno | abnormal supraoccipital bone morphology | 9.36e-04 | 29 | 22 | 2 | MP:0000078 | |
| MousePheno | abnormal epidermis stratum corneum morphology | 1.11e-03 | 132 | 22 | 3 | MP:0001240 | |
| MousePheno | abnormal rostral-caudal axis patterning | 1.11e-03 | 132 | 22 | 3 | MP:0005221 | |
| MousePheno | abnormal breathing pattern | 1.16e-03 | 303 | 22 | 4 | MP:0001951 | |
| MousePheno | digestive/alimentary phenotype | 1.39e-03 | 1500 | 22 | 8 | MP:0005381 | |
| Domain | Keratin_I | 2.94e-09 | 44 | 25 | 5 | IPR002957 | |
| Domain | Intermediate_filament_CS | 1.87e-08 | 63 | 25 | 5 | IPR018039 | |
| Domain | Filament | 3.45e-08 | 71 | 25 | 5 | SM01391 | |
| Domain | IF | 3.70e-08 | 72 | 25 | 5 | PS00226 | |
| Domain | Filament | 3.97e-08 | 73 | 25 | 5 | PF00038 | |
| Domain | IF | 4.87e-08 | 76 | 25 | 5 | IPR001664 | |
| Domain | HnRNPA1 | 5.16e-06 | 3 | 25 | 2 | PF11627 | |
| Domain | HnRNPA1 | 5.16e-06 | 3 | 25 | 2 | IPR021662 | |
| Domain | Ski_Sno | 3.60e-05 | 7 | 25 | 2 | PF02437 | |
| Domain | - | 3.60e-05 | 7 | 25 | 2 | 3.10.260.20 | |
| Domain | Transform_Ski | 3.60e-05 | 7 | 25 | 2 | IPR003380 | |
| Domain | DNA-bd_dom_put | 9.39e-05 | 11 | 25 | 2 | IPR009061 | |
| Domain | Prefoldin | 1.19e-04 | 72 | 25 | 3 | IPR009053 | |
| Domain | RRM_1 | 2.61e-03 | 208 | 25 | 3 | PF00076 | |
| Domain | RRM | 2.95e-03 | 217 | 25 | 3 | SM00360 | |
| Domain | RRM_dom | 3.34e-03 | 227 | 25 | 3 | IPR000504 | |
| Domain | RRM | 3.47e-03 | 230 | 25 | 3 | PS50102 | |
| Domain | - | 4.10e-03 | 244 | 25 | 3 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 4.79e-03 | 258 | 25 | 3 | IPR012677 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 8.66e-08 | 87 | 19 | 5 | MM15351 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 6.23e-07 | 129 | 19 | 5 | M27649 | |
| Pathway | REACTOME_KERATINIZATION | 1.45e-06 | 153 | 19 | 5 | MM15343 | |
| Pathway | REACTOME_KERATINIZATION | 8.05e-06 | 217 | 19 | 5 | M27640 | |
| Pathway | REACTOME_DIFFERENTIATION_OF_KERATINOCYTES_IN_INTERFOLLICULAR_EPIDERMIS_IN_MAMMALIAN_SKIN | 1.99e-05 | 40 | 19 | 3 | M48231 | |
| Pathway | WP_MRNA_PROCESSING | 2.63e-04 | 451 | 19 | 5 | MM15946 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 4.31e-04 | 502 | 19 | 5 | MM14537 | |
| Pubmed | 1.53e-12 | 346 | 25 | 9 | 25324306 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 2.19e-10 | 605 | 25 | 9 | 28977666 | |
| Pubmed | 5.12e-10 | 57 | 25 | 5 | 31862882 | ||
| Pubmed | 8.57e-10 | 63 | 25 | 5 | 16831889 | ||
| Pubmed | 1.00e-09 | 286 | 25 | 7 | 32041737 | ||
| Pubmed | 1.01e-09 | 65 | 25 | 5 | 29795372 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | KRT1 SRP68 KRT9 KRT10 KRT13 FUS ILF3 FAM98B KRT15 KLHDC10 HNRNPA2B1 | 1.28e-09 | 1415 | 25 | 11 | 28515276 |
| Pubmed | 2.18e-09 | 24 | 25 | 4 | 30719818 | ||
| Pubmed | 2.18e-09 | 24 | 25 | 4 | 27507811 | ||
| Pubmed | ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. | 3.06e-09 | 336 | 25 | 7 | 31253590 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 3.10e-09 | 1149 | 25 | 10 | 35446349 | |
| Pubmed | KRT1 SRP68 KRT9 KRT10 KRT13 HNRNPA1L2 FUS ILF3 KRT15 HNRNPA2B1 | 3.20e-09 | 1153 | 25 | 10 | 29845934 | |
| Pubmed | Sox21 Regulates Anapc10 Expression and Determines the Fate of Ectodermal Organ. | 4.20e-09 | 28 | 25 | 4 | 32674056 | |
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | 5.59e-09 | 91 | 25 | 5 | 34445801 | |
| Pubmed | Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease. | 1.37e-08 | 418 | 25 | 7 | 32552912 | |
| Pubmed | 1.44e-08 | 421 | 25 | 7 | 34650049 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 1.62e-08 | 678 | 25 | 8 | 30209976 | |
| Pubmed | KRT1 KRT10 KRT13 HNRNPA1L2 FUS ILF3 FAM98B KRT15 HNRNPA2B1 FUBP1 | 2.69e-08 | 1442 | 25 | 10 | 35575683 | |
| Pubmed | 2.97e-08 | 266 | 25 | 6 | 19380743 | ||
| Pubmed | 3.03e-08 | 45 | 25 | 4 | 30619335 | ||
| Pubmed | 3.92e-08 | 10 | 25 | 3 | 24940650 | ||
| Pubmed | E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis. | 4.08e-08 | 135 | 25 | 5 | 29859926 | |
| Pubmed | 4.13e-08 | 491 | 25 | 7 | 22623428 | ||
| Pubmed | 5.39e-08 | 11 | 25 | 3 | 16085486 | ||
| Pubmed | 5.81e-08 | 298 | 25 | 6 | 30737378 | ||
| Pubmed | 9.85e-08 | 60 | 25 | 4 | 31220272 | ||
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 9.86e-08 | 558 | 25 | 7 | 27591049 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 1.24e-07 | 1257 | 25 | 9 | 36526897 | |
| Pubmed | Multiple roles of Notch signaling in the regulation of epidermal development. | 1.48e-07 | 15 | 25 | 3 | 18410734 | |
| Pubmed | 1.48e-07 | 15 | 25 | 3 | 10087197 | ||
| Pubmed | 1.83e-07 | 16 | 25 | 3 | 17631878 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 1.85e-07 | 1318 | 25 | 9 | 30463901 | |
| Pubmed | 2.07e-07 | 187 | 25 | 5 | 29777862 | ||
| Pubmed | 2.18e-07 | 73 | 25 | 4 | 35973989 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 2.22e-07 | 954 | 25 | 8 | 36373674 | |
| Pubmed | 2.44e-07 | 75 | 25 | 4 | 31527668 | ||
| Pubmed | Dlx3 is a crucial regulator of hair follicle differentiation and cycling. | 2.66e-07 | 18 | 25 | 3 | 18684741 | |
| Pubmed | 2.66e-07 | 18 | 25 | 3 | 20335364 | ||
| Pubmed | 3.15e-07 | 19 | 25 | 3 | 35173535 | ||
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 3.85e-07 | 84 | 25 | 4 | 29563501 | |
| Pubmed | EEF1D Promotes Glioma Proliferation, Migration, and Invasion through EMT and PI3K/Akt Pathway. | 4.33e-07 | 21 | 25 | 3 | 33029523 | |
| Pubmed | HDM2-binding partners: interaction with translation elongation factor EF1alpha. | 4.33e-07 | 21 | 25 | 3 | 17373842 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | 4.73e-07 | 704 | 25 | 7 | 32994395 | |
| Pubmed | 4.87e-07 | 707 | 25 | 7 | 19738201 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 1380247 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 31036554 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 23182068 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 34199056 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 27722766 | ||
| Pubmed | Chromosomal mapping of human keratin genes: evidence of non-linkage. | 4.96e-07 | 2 | 25 | 2 | 2461420 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 22375063 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 27595935 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 7507152 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 21271994 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 27421141 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 7504553 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 35623459 | ||
| Pubmed | Analysis of KRT1, KRT10, KRT19, TP53 and MMP9 expression in pediatric and adult cholesteatoma. | 4.96e-07 | 2 | 25 | 2 | 30021014 | |
| Pubmed | Mutations in the rod domains of keratins 1 and 10 in epidermolytic hyperkeratosis. | 4.96e-07 | 2 | 25 | 2 | 1380725 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 1379726 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 7512983 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 5.01e-07 | 430 | 25 | 6 | 38172120 | |
| Pubmed | 5.01e-07 | 22 | 25 | 3 | 12456657 | ||
| Pubmed | 5.06e-07 | 711 | 25 | 7 | 33022573 | ||
| Pubmed | FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis. | 5.07e-07 | 224 | 25 | 5 | 28443643 | |
| Pubmed | 5.76e-07 | 23 | 25 | 3 | 11487543 | ||
| Pubmed | 5.76e-07 | 725 | 25 | 7 | 27025967 | ||
| Pubmed | Proteomics analysis of the estrogen receptor alpha receptosome. | 5.80e-07 | 93 | 25 | 4 | 20348541 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 6.03e-07 | 232 | 25 | 5 | 25515538 | |
| Pubmed | 6.57e-07 | 24 | 25 | 3 | 28589954 | ||
| Pubmed | Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. | 6.59e-07 | 96 | 25 | 4 | 25948554 | |
| Pubmed | 6.67e-07 | 1103 | 25 | 8 | 34189442 | ||
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 6.84e-07 | 238 | 25 | 5 | 35864588 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 7.61e-07 | 462 | 25 | 6 | 31138677 | |
| Pubmed | KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. | 9.09e-07 | 104 | 25 | 4 | 36055981 | |
| Pubmed | mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation. | 9.49e-07 | 27 | 25 | 3 | 27807348 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 1.02e-06 | 258 | 25 | 5 | 37794589 | |
| Pubmed | 1.05e-06 | 488 | 25 | 6 | 31324722 | ||
| Pubmed | Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. | 1.32e-06 | 30 | 25 | 3 | 15782174 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 8603923 | ||
| Pubmed | A widespread sequence-specific mRNA decay pathway mediated by hnRNPs A1 and A2/B1. | 1.49e-06 | 3 | 25 | 2 | 27151978 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 7535287 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 7509717 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 18637039 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 26581228 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 28343865 | ||
| Pubmed | 1.59e-06 | 844 | 25 | 7 | 25963833 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.60e-06 | 283 | 25 | 5 | 30585729 | |
| Pubmed | MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | 1.72e-06 | 287 | 25 | 5 | 36180891 | |
| Pubmed | 1.96e-06 | 295 | 25 | 5 | 26209609 | ||
| Pubmed | 2.22e-06 | 130 | 25 | 4 | 19386638 | ||
| Pubmed | 2.31e-06 | 305 | 25 | 5 | 33194618 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 2.41e-06 | 564 | 25 | 6 | 21565611 | |
| Pubmed | 2.50e-06 | 134 | 25 | 4 | 19030180 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 2.57e-06 | 908 | 25 | 7 | 19274049 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 2.83e-06 | 580 | 25 | 6 | 35676659 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 2.85e-06 | 922 | 25 | 7 | 27609421 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 7679677 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 21940735 | ||
| Pubmed | Transcription Factors Runx1 and Runx3 Suppress Keratin Expression in Undifferentiated Keratinocytes. | 2.97e-06 | 4 | 25 | 2 | 36077435 | |
| Interaction | NEDD8 interactions | 1.58e-08 | 393 | 25 | 8 | int:NEDD8 | |
| Interaction | MYCN interactions | KRT1 SRP68 KRT9 KRT10 HNRNPA1L2 FOXK2 FUS ILF3 FAM98B KLHDC10 HNRNPA2B1 FUBP1 | 2.16e-08 | 1373 | 25 | 12 | int:MYCN |
| Interaction | MINDY4 interactions | 2.72e-08 | 73 | 25 | 5 | int:MINDY4 | |
| Interaction | RNF208 interactions | 3.13e-08 | 75 | 25 | 5 | int:RNF208 | |
| Interaction | DCUN1D1 interactions | 3.18e-08 | 275 | 25 | 7 | int:DCUN1D1 | |
| Interaction | MEPCE interactions | KRT1 SRP68 KRT9 KRT10 KRT13 HNRNPA1L2 FUS ILF3 KRT15 HNRNPA2B1 | 3.43e-08 | 859 | 25 | 10 | int:MEPCE |
| Interaction | DDX3X interactions | 4.66e-08 | 651 | 25 | 9 | int:DDX3X | |
| Interaction | HEXIM1 interactions | KRT1 SRP68 KRT9 KRT10 KRT13 HNRNPA1L2 FUS ILF3 KRT15 HNRNPA2B1 | 6.09e-08 | 913 | 25 | 10 | int:HEXIM1 |
| Interaction | CHD4 interactions | 7.85e-08 | 938 | 25 | 10 | int:CHD4 | |
| Interaction | HNRNPA1 interactions | KRT1 KRT9 KRT10 HNRNPA1L2 FUS ILF3 FAM98B KRT15 HNRNPA2B1 FUBP1 | 8.42e-08 | 945 | 25 | 10 | int:HNRNPA1 |
| Interaction | CUL4B interactions | 1.21e-07 | 728 | 25 | 9 | int:CUL4B | |
| Interaction | FBP1 interactions | 1.59e-07 | 348 | 25 | 7 | int:FBP1 | |
| Interaction | CHD3 interactions | 1.69e-07 | 757 | 25 | 9 | int:CHD3 | |
| Interaction | PIK3R2 interactions | 3.06e-07 | 230 | 25 | 6 | int:PIK3R2 | |
| Interaction | COPS5 interactions | 3.53e-07 | 1102 | 25 | 10 | int:COPS5 | |
| Interaction | CUL2 interactions | 3.63e-07 | 591 | 25 | 8 | int:CUL2 | |
| Interaction | KRT17 interactions | 5.23e-07 | 252 | 25 | 6 | int:KRT17 | |
| Interaction | CYLD interactions | 5.36e-07 | 868 | 25 | 9 | int:CYLD | |
| Interaction | RPS6KB2 interactions | 6.42e-07 | 261 | 25 | 6 | int:RPS6KB2 | |
| Interaction | MAGOH interactions | 6.86e-07 | 264 | 25 | 6 | int:MAGOH | |
| Interaction | CAND1 interactions | 6.87e-07 | 894 | 25 | 9 | int:CAND1 | |
| Interaction | TRIM31 interactions | 9.51e-07 | 454 | 25 | 7 | int:TRIM31 | |
| Interaction | RIN3 interactions | 1.08e-06 | 463 | 25 | 7 | int:RIN3 | |
| Interaction | VCAM1 interactions | 1.29e-06 | 475 | 25 | 7 | int:VCAM1 | |
| Interaction | BAP1 interactions | 1.78e-06 | 1314 | 25 | 10 | int:BAP1 | |
| Interaction | EIF4A3 interactions | 1.79e-06 | 499 | 25 | 7 | int:EIF4A3 | |
| Interaction | ARIH2 interactions | 1.88e-06 | 314 | 25 | 6 | int:ARIH2 | |
| Interaction | KRT7 interactions | 2.73e-06 | 80 | 25 | 4 | int:KRT7 | |
| Interaction | PRPF8 interactions | 2.81e-06 | 776 | 25 | 8 | int:PRPF8 | |
| Interaction | TNF interactions | 2.98e-06 | 340 | 25 | 6 | int:TNF | |
| Interaction | ARL16 interactions | 3.17e-06 | 83 | 25 | 4 | int:ARL16 | |
| Interaction | ITGA4 interactions | 3.28e-06 | 547 | 25 | 7 | int:ITGA4 | |
| Interaction | METTL14 interactions | 3.74e-06 | 558 | 25 | 7 | int:METTL14 | |
| Interaction | CUL5 interactions | 4.16e-06 | 567 | 25 | 7 | int:CUL5 | |
| Interaction | LARP7 interactions | 4.23e-06 | 1113 | 25 | 9 | int:LARP7 | |
| Interaction | SHC1 interactions | 4.28e-06 | 362 | 25 | 6 | int:SHC1 | |
| Interaction | POU5F1 interactions | 5.05e-06 | 584 | 25 | 7 | int:POU5F1 | |
| Interaction | CUL1 interactions | 6.90e-06 | 876 | 25 | 8 | int:CUL1 | |
| Interaction | COPS6 interactions | 8.48e-06 | 408 | 25 | 6 | int:COPS6 | |
| Interaction | KRT1 interactions | 9.65e-06 | 238 | 25 | 5 | int:KRT1 | |
| Interaction | DDRGK1 interactions | 1.08e-05 | 1249 | 25 | 9 | int:DDRGK1 | |
| Interaction | RC3H2 interactions | 1.20e-05 | 667 | 25 | 7 | int:RC3H2 | |
| Interaction | KRT74 interactions | 1.27e-05 | 37 | 25 | 3 | int:KRT74 | |
| Interaction | RC3H1 interactions | 1.33e-05 | 677 | 25 | 7 | int:RC3H1 | |
| Interaction | CDK9 interactions | 1.43e-05 | 685 | 25 | 7 | int:CDK9 | |
| Interaction | SMC5 interactions | 1.81e-05 | 1000 | 25 | 8 | int:SMC5 | |
| Interaction | METTL3 interactions | 2.38e-05 | 287 | 25 | 5 | int:METTL3 | |
| Interaction | IKZF1 interactions | 2.42e-05 | 288 | 25 | 5 | int:IKZF1 | |
| Interaction | NR2C2 interactions | 2.75e-05 | 1403 | 25 | 9 | int:NR2C2 | |
| Interaction | IGF2BP3 interactions | 2.93e-05 | 508 | 25 | 6 | int:IGF2BP3 | |
| Interaction | ARL4D interactions | 2.97e-05 | 146 | 25 | 4 | int:ARL4D | |
| Interaction | SOX2 interactions | 3.06e-05 | 1422 | 25 | 9 | int:SOX2 | |
| Interaction | MCM2 interactions | 3.18e-05 | 1081 | 25 | 8 | int:MCM2 | |
| Interaction | YAP1 interactions | 3.49e-05 | 1095 | 25 | 8 | int:YAP1 | |
| Interaction | EFTUD2 interactions | 3.56e-05 | 1449 | 25 | 9 | int:EFTUD2 | |
| Interaction | DIRAS2 interactions | 3.58e-05 | 52 | 25 | 3 | int:DIRAS2 | |
| Interaction | ACE2 interactions | 3.75e-05 | 1106 | 25 | 8 | int:ACE2 | |
| Interaction | TP53BP1 interactions | 3.84e-05 | 533 | 25 | 6 | int:TP53BP1 | |
| Interaction | UBASH3B interactions | 3.95e-05 | 157 | 25 | 4 | int:UBASH3B | |
| Interaction | DES interactions | 4.05e-05 | 158 | 25 | 4 | int:DES | |
| Interaction | HDGF interactions | 4.06e-05 | 321 | 25 | 5 | int:HDGF | |
| Interaction | GRB2 interactions | 4.08e-05 | 806 | 25 | 7 | int:GRB2 | |
| Interaction | ASXL3 interactions | 4.79e-05 | 165 | 25 | 4 | int:ASXL3 | |
| Interaction | FAF1 interactions | 4.91e-05 | 334 | 25 | 5 | int:FAF1 | |
| Interaction | DDX39B interactions | 5.58e-05 | 570 | 25 | 6 | int:DDX39B | |
| Interaction | FN1 interactions | 5.63e-05 | 848 | 25 | 7 | int:FN1 | |
| Interaction | ZUP1 interactions | 5.89e-05 | 174 | 25 | 4 | int:ZUP1 | |
| Interaction | HDAC2 interactions | 6.38e-05 | 865 | 25 | 7 | int:HDAC2 | |
| Interaction | NKX2-1 interactions | 6.72e-05 | 180 | 25 | 4 | int:NKX2-1 | |
| Interaction | KRT75 interactions | 6.87e-05 | 181 | 25 | 4 | int:KRT75 | |
| Interaction | IQCB1 interactions | 7.97e-05 | 370 | 25 | 5 | int:IQCB1 | |
| Interaction | CRK interactions | 7.97e-05 | 370 | 25 | 5 | int:CRK | |
| Interaction | MIR138-1 interactions | 8.01e-05 | 68 | 25 | 3 | int:MIR138-1 | |
| Interaction | HSF1 interactions | 8.05e-05 | 609 | 25 | 6 | int:HSF1 | |
| Interaction | FCMR interactions | 8.07e-05 | 11 | 25 | 2 | int:FCMR | |
| Interaction | ARL10 interactions | 8.12e-05 | 189 | 25 | 4 | int:ARL10 | |
| Interaction | ARAF interactions | 8.60e-05 | 376 | 25 | 5 | int:ARAF | |
| Interaction | PABPN1 interactions | 8.64e-05 | 192 | 25 | 4 | int:PABPN1 | |
| Interaction | CEBPA interactions | 8.70e-05 | 1245 | 25 | 8 | int:CEBPA | |
| Interaction | KRT5 interactions | 8.81e-05 | 193 | 25 | 4 | int:KRT5 | |
| Interaction | XRN2 interactions | 9.15e-05 | 381 | 25 | 5 | int:XRN2 | |
| Interaction | MIDN interactions | 9.38e-05 | 626 | 25 | 6 | int:MIDN | |
| Interaction | PHGDH interactions | 9.61e-05 | 385 | 25 | 5 | int:PHGDH | |
| Interaction | HDAC6 interactions | 1.00e-04 | 929 | 25 | 7 | int:HDAC6 | |
| Interaction | ALB interactions | 1.03e-04 | 391 | 25 | 5 | int:ALB | |
| Interaction | PRPH interactions | 1.09e-04 | 204 | 25 | 4 | int:PRPH | |
| Interaction | MIR16-1 interactions | 1.12e-04 | 76 | 25 | 3 | int:MIR16-1 | |
| Interaction | MIR199A2 interactions | 1.12e-04 | 76 | 25 | 3 | int:MIR199A2 | |
| Interaction | MIR7-3 interactions | 1.12e-04 | 76 | 25 | 3 | int:MIR7-3 | |
| Interaction | OGT interactions | 1.15e-04 | 950 | 25 | 7 | int:OGT | |
| Interaction | TNIP2 interactions | 1.17e-04 | 952 | 25 | 7 | int:TNIP2 | |
| Interaction | AAR2 interactions | 1.22e-04 | 657 | 25 | 6 | int:AAR2 | |
| Interaction | MIR222 interactions | 1.25e-04 | 79 | 25 | 3 | int:MIR222 | |
| Interaction | PTMA interactions | 1.27e-04 | 212 | 25 | 4 | int:PTMA | |
| Interaction | CFAP57 interactions | 1.33e-04 | 14 | 25 | 2 | int:CFAP57 | |
| Interaction | MIR10B interactions | 1.40e-04 | 82 | 25 | 3 | int:MIR10B | |
| Interaction | AHI1 interactions | 1.45e-04 | 83 | 25 | 3 | int:AHI1 | |
| Interaction | MIR106A interactions | 1.45e-04 | 83 | 25 | 3 | int:MIR106A | |
| Interaction | EPS15 interactions | 1.46e-04 | 220 | 25 | 4 | int:EPS15 | |
| Interaction | KRT76 interactions | 1.50e-04 | 84 | 25 | 3 | int:KRT76 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.19e-04 | 473 | 25 | 4 | chr17q21 | |
| GeneFamily | Keratins, type I | 1.39e-08 | 28 | 18 | 4 | 608 | |
| GeneFamily | RNA binding motif containing | 1.15e-03 | 213 | 18 | 3 | 725 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.26e-02 | 718 | 18 | 3 | 28 | |
| Coexpression | LIU_CDX2_TARGETS_DN | 4.28e-08 | 8 | 25 | 3 | M19218 | |
| Coexpression | MURAKAMI_UV_RESPONSE_1HR_UP | 3.46e-07 | 15 | 25 | 3 | M13308 | |
| Coexpression | BENPORATH_ES_CORE_NINE_CORRELATED | 2.37e-06 | 100 | 25 | 4 | M14079 | |
| Coexpression | GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_DN | 3.67e-05 | 200 | 25 | 4 | M7646 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_2H_BMDC_DN | 3.67e-05 | 200 | 25 | 4 | M3802 | |
| Coexpression | FOURNIER_ACINAR_DEVELOPMENT_LATE_UP | 4.78e-05 | 11 | 25 | 2 | M644 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 8.52e-05 | 90 | 25 | 3 | M39250 | |
| Coexpression | CAMPS_COLON_CANCER_COPY_NUMBER_UP | 9.40e-05 | 93 | 25 | 3 | M18750 | |
| Coexpression | TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA | 1.24e-04 | 102 | 25 | 3 | M14455 | |
| Coexpression | ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN | 1.39e-04 | 106 | 25 | 3 | M9160 | |
| Coexpression | MURAKAMI_UV_RESPONSE_24HR | 1.64e-04 | 20 | 25 | 2 | M17175 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | 1.74e-04 | 568 | 25 | 5 | MM3824 | |
| Coexpression | MURAKAMI_UV_RESPONSE_6HR_DN | 1.81e-04 | 21 | 25 | 2 | M16756 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TREG_DN | 2.15e-04 | 123 | 25 | 3 | M8953 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 2.33e-04 | 323 | 25 | 4 | M9150 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 2.71e-04 | 133 | 25 | 3 | M8880 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 2.95e-04 | 137 | 25 | 3 | MM990 | |
| Coexpression | DORN_ADENOVIRUS_INFECTION_12HR_UP | 3.25e-04 | 28 | 25 | 2 | M10668 | |
| Coexpression | KRAS.LUNG_UP.V1_DN | 3.28e-04 | 142 | 25 | 3 | M2893 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_D_UP | 3.35e-04 | 143 | 25 | 3 | M16927 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_D_UP | 3.35e-04 | 143 | 25 | 3 | MM788 | |
| Coexpression | LOPEZ_TRANSLATION_VIA_FN1_SIGNALING | 5.10e-04 | 35 | 25 | 2 | M2426 | |
| Coexpression | ONDER_CDH1_TARGETS_1_DN | 5.55e-04 | 170 | 25 | 3 | M6822 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 5.84e-04 | 173 | 25 | 3 | M650 | |
| Coexpression | DORN_ADENOVIRUS_INFECTION_32HR_DN | 6.01e-04 | 38 | 25 | 2 | M15590 | |
| Coexpression | GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP | 6.66e-04 | 181 | 25 | 3 | M6849 | |
| Coexpression | GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP | 6.77e-04 | 182 | 25 | 3 | M7624 | |
| Coexpression | PRC2_SUZ12_UP.V1_UP | 7.10e-04 | 185 | 25 | 3 | M2741 | |
| Coexpression | DORN_ADENOVIRUS_INFECTION_24HR_DN | 7.35e-04 | 42 | 25 | 2 | M8825 | |
| Coexpression | GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_DN | 7.44e-04 | 188 | 25 | 3 | M367 | |
| Coexpression | ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN | 7.70e-04 | 43 | 25 | 2 | M17794 | |
| Coexpression | CYCLIN_D1_KE_.V1_DN | 7.78e-04 | 191 | 25 | 3 | M2647 | |
| Coexpression | GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_UP | 8.02e-04 | 193 | 25 | 3 | M3549 | |
| Coexpression | GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_DN | 8.14e-04 | 194 | 25 | 3 | M7573 | |
| Coexpression | GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP | 8.64e-04 | 198 | 25 | 3 | M3601 | |
| Coexpression | GSE25087_FETAL_VS_ADULT_TCONV_UP | 8.77e-04 | 199 | 25 | 3 | M4645 | |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_MAC_DN | 8.77e-04 | 199 | 25 | 3 | M5159 | |
| Coexpression | GSE36009_WT_VS_NLRP10_KO_DC_DN | 8.77e-04 | 199 | 25 | 3 | M8777 | |
| Coexpression | GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_UP | 8.77e-04 | 199 | 25 | 3 | M7845 | |
| Coexpression | GSE24726_WT_VS_E2_2_KO_PDC_DN | 8.89e-04 | 200 | 25 | 3 | M8061 | |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP | 8.89e-04 | 200 | 25 | 3 | M387 | |
| Coexpression | GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_DN | 8.89e-04 | 200 | 25 | 3 | M7653 | |
| Coexpression | GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP | 8.89e-04 | 200 | 25 | 3 | M5797 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_UP | 8.89e-04 | 200 | 25 | 3 | M8843 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_UP | 8.89e-04 | 200 | 25 | 3 | M7903 | |
| Coexpression | GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP | 8.89e-04 | 200 | 25 | 3 | M6613 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP | 8.89e-04 | 200 | 25 | 3 | M5168 | |
| Coexpression | GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP | 8.89e-04 | 200 | 25 | 3 | M8212 | |
| Coexpression | GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_DN | 8.89e-04 | 200 | 25 | 3 | M9539 | |
| Coexpression | HALLMARK_KRAS_SIGNALING_DN | 8.89e-04 | 200 | 25 | 3 | M5956 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 9.42e-04 | 204 | 25 | 3 | MM966 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_39 | 9.42e-04 | 204 | 25 | 3 | MM17090 | |
| Coexpression | CROMER_TUMORIGENESIS_DN | 9.99e-04 | 49 | 25 | 2 | M16948 | |
| Coexpression | CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS | 1.04e-03 | 50 | 25 | 2 | M1702 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.13e-03 | 856 | 25 | 5 | M4500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | 1.60e-05 | 769 | 24 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | 2.39e-05 | 818 | 24 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#2_top-relative-expression-ranked_100 | 6.69e-05 | 11 | 24 | 2 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k2_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | 1.01e-04 | 428 | 24 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | 1.02e-04 | 429 | 24 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_100 | 1.80e-04 | 98 | 24 | 3 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.80e-04 | 98 | 24 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 1.85e-04 | 18 | 24 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#4_top-relative-expression-ranked_200 | 1.85e-04 | 18 | 24 | 2 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k4_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500 | 1.91e-04 | 491 | 24 | 5 | Facebase_RNAseq_e9.5_Olfactory Placode_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 2.04e-04 | 498 | 24 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#3_top-relative-expression-ranked_100 | 2.07e-04 | 19 | 24 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#2_top-relative-expression-ranked_100 | 2.30e-04 | 20 | 24 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_100_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_200 | 2.54e-04 | 21 | 24 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_200_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | 2.68e-04 | 836 | 24 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#3_top-relative-expression-ranked_200 | 2.79e-04 | 22 | 24 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_200_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#2_top-relative-expression-ranked_200 | 3.05e-04 | 23 | 24 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_100 | 3.05e-04 | 23 | 24 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_100_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.11e-04 | 118 | 24 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_200 | 3.33e-04 | 24 | 24 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_500 | 3.62e-04 | 25 | 24 | 2 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.13e-04 | 130 | 24 | 3 | gudmap_developingGonad_e12.5_ovary_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#1_top-relative-expression-ranked_500 | 4.55e-04 | 28 | 24 | 2 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k1_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | 6.03e-04 | 973 | 24 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_200 | 6.33e-04 | 33 | 24 | 2 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_500 | 6.33e-04 | 33 | 24 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 6.57e-04 | 989 | 24 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_200 | 8.27e-04 | 165 | 24 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#5_top-relative-expression-ranked_200 | 8.84e-04 | 39 | 24 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#4_top-relative-expression-ranked_200 | 8.84e-04 | 39 | 24 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_200 | 8.86e-04 | 169 | 24 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_200 | |
| CoexpressionAtlas | MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 9.46e-04 | 1479 | 24 | 7 | PCBC_ratio_MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#2 | 9.77e-04 | 41 | 24 | 2 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_200 | 9.80e-04 | 175 | 24 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_200 | 1.03e-03 | 178 | 24 | 3 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 1.04e-03 | 407 | 24 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 1.05e-03 | 408 | 24 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#4 | 1.13e-03 | 44 | 24 | 2 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500_K4 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500 | 1.25e-03 | 427 | 24 | 4 | Facebase_ST1_Univ_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_500 | 1.28e-03 | 47 | 24 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k5 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_250 | 1.57e-03 | 206 | 24 | 3 | Facebase_ST1_Univ_250 | |
| CoexpressionAtlas | skin | 1.59e-03 | 456 | 24 | 4 | skin | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#2 | 1.75e-03 | 55 | 24 | 2 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_1000 | 1.75e-03 | 800 | 24 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.79e-03 | 471 | 24 | 4 | ratio_ECTO_vs_SC_1000_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | 1.81e-03 | 806 | 24 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.82e-03 | 56 | 24 | 2 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.95e-03 | 58 | 24 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#1_top-relative-expression-ranked_200 | 2.01e-03 | 59 | 24 | 2 | gudmap_developingLowerUrinaryTract_adult_ureter_200_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 2.11e-03 | 493 | 24 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 2.15e-03 | 61 | 24 | 2 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#1_top-relative-expression-ranked_500 | 2.15e-03 | 61 | 24 | 2 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k1_500 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.19e-08 | 136 | 25 | 5 | 3e13dc0634f3b05e9f9e6c3193f843f62e603b78 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.19e-08 | 136 | 25 | 5 | 0185486c39700dd2f72d79be6d283494dd8379c9 | |
| ToppCell | Striatum|World / BrainAtlas - Mouse McCarroll V32 | 3.85e-08 | 172 | 25 | 5 | 8da598d209b8a6646b9f4de1aed833f6fcbb9909 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.83e-08 | 180 | 25 | 5 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 2.08e-06 | 165 | 25 | 4 | 7b992843bd8ef92a7a76b1d681fa84efde6f5bdd | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.75e-06 | 177 | 25 | 4 | aadf1d10eccfb014cf3d621b1f01dd6d76df63ac | |
| ToppCell | C_00|World / shred on cell type and cluster | 2.87e-06 | 179 | 25 | 4 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-06 | 186 | 25 | 4 | 11929e36d8c9b4c4bc2f5e912f139f474f91ab00 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.64e-06 | 190 | 25 | 4 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 4.46e-06 | 200 | 25 | 4 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 4.46e-06 | 200 | 25 | 4 | ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Meis2-Meis2_Adamts19|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.75e-06 | 69 | 25 | 3 | 130b1a56afe6aee01cde56cb983cbc2c41861bb4 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Meis2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.75e-06 | 69 | 25 | 3 | 6568fcefcc0dca211f2acf6e4066f795489e758d | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.81e-06 | 72 | 25 | 3 | 0bc1df0405fe854e0364f44b9dacc39b115a9b77 | |
| ToppCell | Control-PLT_5|World / Disease Group and Platelet Clusters | 4.72e-05 | 126 | 25 | 3 | 4ba753c4e83eb1d41964edfa22135e047f06c481 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.05e-05 | 137 | 25 | 3 | ed81624b9167255ce88dcf6ad7f1636376ea0525 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell-Mesenchymal_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.05e-05 | 137 | 25 | 3 | 47859aa25f32367461c1ec75ed9060bee430c6b7 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.61e-05 | 148 | 25 | 3 | afebb64365c94b9476494bffe7c364677f19c8cf | |
| ToppCell | Thalamus-Neuronal-Inhibitory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.61e-05 | 148 | 25 | 3 | 5f82e5ecacfd223020b8ee975c17d68c1fe6db38 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.76e-05 | 149 | 25 | 3 | d259e9137109eeb2662022f0915ca463f5bebdfe | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.92e-05 | 150 | 25 | 3 | aa11579a57d671a55e64183d35c1340fda6dec14 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.39e-05 | 153 | 25 | 3 | 82b77c8bae49dd63b8f10eb67df66ca71d0bb315 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 9.06e-05 | 157 | 25 | 3 | 2553ebf3e48de5bd184e77bd61114faa5a1d95ed | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.41e-05 | 159 | 25 | 3 | 0dccc4275b9b4f8554dd556da7218e130bff8fd1 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.41e-05 | 159 | 25 | 3 | 7f29f9dcf25ffa1822b137c571e9ac16defc6292 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.41e-05 | 159 | 25 | 3 | a8fa49dc2e6ad726d1f4f2b30693fecd1151a485 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.41e-05 | 159 | 25 | 3 | 95834b767cfb4fb8c5aeea89c10f3e14a1fd15c1 | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 162 | 25 | 3 | 497ae9f86a5e7946d0fde932b35719a382a6b691 | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 162 | 25 | 3 | 7b2949eba2b4aea239d96ed82aafab13b07624eb | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.01e-04 | 163 | 25 | 3 | bba830a302919c8b33f914a8839877fc21dd28a0 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.01e-04 | 163 | 25 | 3 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.03e-04 | 164 | 25 | 3 | 08819970174a3eb4eee8e1e675075828665b845e | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 165 | 25 | 3 | 0ae39c9a6d1265d65dc0660924612cfe11e489ec | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-04 | 165 | 25 | 3 | e381bcd558745f3a60346f78b49d0b2672184baa | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 165 | 25 | 3 | 686cf89077cc7b744a6127de2b34d8c27da8b6c4 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 165 | 25 | 3 | a5ed8c331d5551cd8bce50bdc31cb893218317cd | |
| ToppCell | COPD-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 1.07e-04 | 166 | 25 | 3 | e2cad1db536d5ad5a34c337c19b5e7d1a2851552 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.09e-04 | 167 | 25 | 3 | 9a84f45345c75f2c8ff38a04245aadee2a26a240 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-04 | 170 | 25 | 3 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-04 | 170 | 25 | 3 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 171 | 25 | 3 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.17e-04 | 171 | 25 | 3 | 5efd15300f865ebf651e0888265cbd717bc3b9d3 | |
| ToppCell | COVID-19_Severe-NK_CD56bright|COVID-19_Severe / Disease condition and Cell class | 1.17e-04 | 171 | 25 | 3 | 5810f790012a0750ca3378595514f66a99f123be | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.19e-04 | 172 | 25 | 3 | 7e1a7700a4c2b1d100da1d6e475e73498ebb605a | |
| ToppCell | COPD-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 1.21e-04 | 173 | 25 | 3 | 4a0043b29f8ede5a74bdb38cbf2c70e12b25e130 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors|lymph-node_spleen / Manually curated celltypes from each tissue | 1.23e-04 | 174 | 25 | 3 | 029394e107bf7ad58056d2216070aa2e964fff12 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.27e-04 | 176 | 25 | 3 | d70fdc7bc48719776ed1e7c01118385e3a21623f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 176 | 25 | 3 | ef0ff02897104e938c8a632357d8f1a6f014e68a | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.27e-04 | 176 | 25 | 3 | a84361308e5e96f3a30246cd29e109c321ee65bf | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 176 | 25 | 3 | da0983929fa682a68e536c298a2d7add188b7563 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-04 | 178 | 25 | 3 | e86ed30652c2de70f16430f04b78789b87df4af2 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 179 | 25 | 3 | 1b979e0203a2ddfe98bf6c2c80c4af1ba437a80f | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-04 | 179 | 25 | 3 | 810972561d1ae5a68389b54ceeac7a49890513a4 | |
| ToppCell | COVID-19_Mild-NK_CD56bright|COVID-19_Mild / Disease condition and Cell class | 1.34e-04 | 179 | 25 | 3 | 90e7a4af195aa2332b07a9f06cde63e72ff49255 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 179 | 25 | 3 | 51872338e54c5f3e42ca9f1c4cf1e8b0cb84afcc | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-04 | 180 | 25 | 3 | 392bc71a69653ba12de31bed4e9357f181094641 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-04 | 181 | 25 | 3 | 8fd64404e57c22c204d835fc5626f73554257b19 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 181 | 25 | 3 | 41969fe4d94ee77b12ecde32170aaf0b13e49644 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 181 | 25 | 3 | 3f50e61dc2a52d71a5801584617607e6246adcf2 | |
| ToppCell | HSPCs-Ery/Mk_prog.|HSPCs / Lineage and Cell class | 1.43e-04 | 183 | 25 | 3 | 59cfb02143b6b54dfca7560562e064948f0340ca | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 1.43e-04 | 183 | 25 | 3 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.43e-04 | 183 | 25 | 3 | f20b0d71f857ac35868fd80531050ad8b6091716 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-3|World / Primary Cells by Cluster | 1.45e-04 | 184 | 25 | 3 | 907ba412166bcb0526c5be0b06a76b6bd37c5a35 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue | 1.45e-04 | 184 | 25 | 3 | d97471a4fe17cba6880ccf1a04cc00c741558124 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 1.45e-04 | 184 | 25 | 3 | 479e60f76c191253e23699c9dd7ef7efc08c59ad | |
| ToppCell | droplet-Skin|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 185 | 25 | 3 | 657fd191ed160f8620d57b33820ec7222806f289 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 185 | 25 | 3 | 98547c1b1828b76da810ed86082182afaaacdb3f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.47e-04 | 185 | 25 | 3 | 79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-04 | 185 | 25 | 3 | e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 185 | 25 | 3 | 5f5df92b328be396941b5812d00454b5ff927d30 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 185 | 25 | 3 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.50e-04 | 186 | 25 | 3 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-04 | 186 | 25 | 3 | b3358e0fa6d845c81e94d56c8575f016621d28ff | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-04 | 187 | 25 | 3 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | facs-SCAT-Fat-3m|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 188 | 25 | 3 | b8dff61240e5052c2fbf7f28b86fe41822df45b0 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.54e-04 | 188 | 25 | 3 | 8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.54e-04 | 188 | 25 | 3 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 25 | 3 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.59e-04 | 190 | 25 | 3 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.59e-04 | 190 | 25 | 3 | f623f0bdece6002b68ac2207e99408b24a2b1194 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-04 | 191 | 25 | 3 | fbd8d337b4444fba8527a614e4a8bfb516ce0f66 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-04 | 191 | 25 | 3 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.62e-04 | 191 | 25 | 3 | 509d17d8ee0d028757ce0f2c9b97e5875f06f0ab | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.62e-04 | 191 | 25 | 3 | 6bc9c7c86040f3ebce08c350e625e345581d4550 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-04 | 191 | 25 | 3 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | severe-Others-CD34+_GATA2+_cells|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.64e-04 | 192 | 25 | 3 | 2e80755627d0350be8976324329e106e808d5574 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.64e-04 | 192 | 25 | 3 | 103496f428f59683ac3ae6147682c07c30663724 | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.67e-04 | 193 | 25 | 3 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.67e-04 | 193 | 25 | 3 | 739fb2a57772a800a2e94bdd6c71285bb2c162a7 | |
| ToppCell | Control-NK_CD56bright|Control / Disease condition and Cell class | 1.67e-04 | 193 | 25 | 3 | 8b1e7a226a6057e1097c1525984127b54e823876 | |
| ToppCell | 15|World / Age, Tissue, Lineage and Cell class | 1.67e-04 | 193 | 25 | 3 | a8ad0de955494d6f5929dc44ba46627d06d95453 | |
| ToppCell | ASK440-Epithelial-Secretory|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.67e-04 | 193 | 25 | 3 | 50e98d91697c7af6a3de39e52edde6dd2b67b512 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.69e-04 | 194 | 25 | 3 | 614d0c25b56957c70f397abb169fd2a860eb1c06 | |
| ToppCell | 10x3'2.3|World / cell types per 3 fetal stages;per 3',per 5' | 1.69e-04 | 194 | 25 | 3 | fc7ed8350ffe1475b8934dfbb107b51991876b0b | |
| ToppCell | BL-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.69e-04 | 194 | 25 | 3 | 2932f704656ca368565ec12f3452af3b18e8df12 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 195 | 25 | 3 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-RG-RG-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.74e-04 | 196 | 25 | 3 | 2e818e0dae640bf398bbbb0081ffa86297adc1c5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-RG-RG|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.74e-04 | 196 | 25 | 3 | 0364a75fb831a9bb43d3b3c9ca1d890f9a68d6ca | |
| ToppCell | NS-critical-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.74e-04 | 196 | 25 | 3 | 97e16d9833e4083d719ca7058d5fc9b11edb37e3 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.74e-04 | 196 | 25 | 3 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| Computational | Keratin. | 6.89e-06 | 26 | 16 | 3 | MODULE_298 | |
| Computational | Genes in the cancer module 68. | 6.89e-06 | 26 | 16 | 3 | MODULE_68 | |
| Computational | Genes in the cancer module 153. | 1.57e-05 | 34 | 16 | 3 | MODULE_153 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.08e-05 | 50 | 16 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN | |
| Computational | Genes in the cancer module 297. | 2.07e-04 | 80 | 16 | 3 | MODULE_297 | |
| Computational | Intermediate filaments and keratins. | 2.07e-04 | 80 | 16 | 3 | MODULE_357 | |
| Computational | Genes in the cancer module 123. | 3.98e-04 | 247 | 16 | 4 | MODULE_123 | |
| Computational | Genes in the cancer module 397. | 7.00e-04 | 121 | 16 | 3 | MODULE_397 | |
| Computational | Neighborhood of FBL | 1.07e-03 | 140 | 16 | 3 | MORF_FBL | |
| Computational | Developmental processes. | 1.23e-03 | 333 | 16 | 4 | MODULE_220 | |
| Computational | Genes in the cancer module 197. | 2.00e-03 | 174 | 16 | 3 | MODULE_197 | |
| Computational | Neighborhood of HAT1 | 2.03e-03 | 175 | 16 | 3 | MORF_HAT1 | |
| Computational | Genes in the cancer module 98. | 2.26e-03 | 393 | 16 | 4 | MODULE_98 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.44e-03 | 50 | 16 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_15_EMT_4 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.44e-03 | 50 | 16 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_STRESS | |
| Computational | Neighborhood of ESPL1 | 3.61e-03 | 61 | 16 | 2 | MORF_ESPL1 | |
| Computational | Nucleotide metabolism. | 3.97e-03 | 64 | 16 | 2 | MODULE_337 | |
| Computational | Neighborhood of DDX5 | 4.09e-03 | 65 | 16 | 2 | GCM_DDX5 | |
| Computational | Neighborhood of UBE2I | 4.85e-03 | 238 | 16 | 3 | MORF_UBE2I | |
| Computational | Neighborhood of CDK2 | 5.00e-03 | 72 | 16 | 2 | MORF_CDK2 | |
| Computational | Genes in the cancer module 32. | 5.02e-03 | 241 | 16 | 3 | MODULE_32 | |
| Computational | Neighborhood of EIF3S2 | 5.32e-03 | 246 | 16 | 3 | MORF_EIF3S2 | |
| Computational | Intermediate filaments. | 5.41e-03 | 75 | 16 | 2 | MODULE_154 | |
| Computational | Neighborhood of HDAC1 | 5.81e-03 | 254 | 16 | 3 | MORF_HDAC1 | |
| Computational | Neighborhood of MYC | 6.14e-03 | 80 | 16 | 2 | MORF_MYC | |
| Computational | Neighborhood of DEK | 6.47e-03 | 264 | 16 | 3 | MORF_DEK | |
| Computational | Neighborhood of PCNA | 6.59e-03 | 83 | 16 | 2 | MORF_PCNA | |
| Computational | Neighborhood of BUB3 | 7.39e-03 | 277 | 16 | 3 | MORF_BUB3 | |
| Computational | Neighborhood of SOD1 | 7.47e-03 | 278 | 16 | 3 | MORF_SOD1 | |
| Computational | Neighborhood of HDAC2 | 7.61e-03 | 280 | 16 | 3 | MORF_HDAC2 | |
| Computational | Neighborhood of CSNK2B | 8.15e-03 | 287 | 16 | 3 | MORF_CSNK2B | |
| Computational | Neighborhood of UBE2N | 8.56e-03 | 95 | 16 | 2 | MORF_UBE2N | |
| Computational | Genes in the cancer module 567. | 8.91e-03 | 97 | 16 | 2 | MODULE_567 | |
| Drug | olomoucine II | 1.95e-08 | 27 | 25 | 4 | CID005494414 | |
| Drug | AC1L9MJT | 5.15e-08 | 192 | 25 | 6 | CID000448959 | |
| Drug | Velcade (bortezomib | 1.14e-07 | 374 | 25 | 7 | CID000093860 | |
| Drug | teleocidin B | 2.07e-07 | 123 | 25 | 5 | CID000072425 | |
| Drug | sulfur mustard | 2.72e-07 | 130 | 25 | 5 | CID000010461 | |
| Drug | homocysteine thiolactone | 2.83e-07 | 131 | 25 | 5 | CID000107712 | |
| Drug | NSC34533 | 3.44e-07 | 54 | 25 | 4 | CID000003512 | |
| Drug | K-11 | 7.87e-07 | 17 | 25 | 3 | CID000469667 | |
| Drug | al-Badry | 8.89e-07 | 165 | 25 | 5 | CID000004545 | |
| Drug | antipsoriatic | 1.05e-06 | 71 | 25 | 4 | CID000005585 | |
| Drug | Bi-E | 3.36e-06 | 27 | 25 | 3 | CID006914595 | |
| Drug | AC1L1GT5 | 3.36e-06 | 95 | 25 | 4 | CID000003829 | |
| Drug | K-13 | 5.15e-06 | 31 | 25 | 3 | CID000469669 | |
| Drug | butyrate | 1.35e-05 | 767 | 25 | 7 | CID000000264 | |
| Drug | 1-2q | 1.37e-05 | 289 | 25 | 5 | CID000011820 | |
| Drug | sandostatinLAR | 1.70e-05 | 143 | 25 | 4 | ctd:C541923 | |
| Drug | NSC134723 | 1.73e-05 | 6 | 25 | 2 | CID000281830 | |
| Drug | phenyl isocyanate | 1.73e-05 | 6 | 25 | 2 | ctd:C025319 | |
| Drug | diallyl trisulfide | 3.21e-05 | 168 | 25 | 4 | ctd:C042577 | |
| Drug | AC1L2B9U | 3.23e-05 | 8 | 25 | 2 | CID000044164 | |
| Drug | CK17 | 3.29e-05 | 57 | 25 | 3 | CID000128831 | |
| Drug | CK 6 | 3.47e-05 | 58 | 25 | 3 | CID000447960 | |
| Drug | Chromates | 4.15e-05 | 9 | 25 | 2 | ctd:D002840 | |
| Drug | ZD0473 | 5.18e-05 | 10 | 25 | 2 | CID006918325 | |
| Drug | Lynestrenol [52-76-6]; Down 200; 14uM; PC3; HT_HG-U133A | 5.62e-05 | 194 | 25 | 4 | 6756_DN | |
| Drug | Medrifar | 5.84e-05 | 69 | 25 | 3 | CID000004043 | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 5.85e-05 | 196 | 25 | 4 | 3353_DN | |
| Drug | Beclomethasone dipropionate [5534-09-8]; Down 200; 7.6uM; PC3; HT_HG-U133A | 5.85e-05 | 196 | 25 | 4 | 4580_DN | |
| Drug | CD437 | 6.70e-05 | 203 | 25 | 4 | CID000135411 | |
| Drug | 4-oxoretinoic acid | 8.11e-05 | 77 | 25 | 3 | CID006437063 | |
| Drug | 1pxm | 8.43e-05 | 78 | 25 | 3 | CID000447959 | |
| Drug | triphenyltin | 8.96e-05 | 13 | 25 | 2 | CID005357402 | |
| Drug | calcium; magnesium | 1.20e-04 | 15 | 25 | 2 | CID014550474 | |
| Drug | AC1O517G | 1.38e-04 | 16 | 25 | 2 | CID006450188 | |
| Drug | picoline | 1.56e-04 | 17 | 25 | 2 | CID000007975 | |
| Drug | K-12 | 1.56e-04 | 17 | 25 | 2 | CID000469668 | |
| Drug | dithranol | 1.75e-04 | 18 | 25 | 2 | CID000002202 | |
| Drug | JTV-519 | 1.75e-04 | 18 | 25 | 2 | CID000001715 | |
| Drug | dichloromethyl | 2.17e-04 | 20 | 25 | 2 | CID000123193 | |
| Drug | bexarotene | 2.40e-04 | 111 | 25 | 3 | CID000082146 | |
| Drug | ZD0473 | 2.40e-04 | 21 | 25 | 2 | CID000177358 | |
| Drug | Lh 1 | 2.64e-04 | 22 | 25 | 2 | CID000191841 | |
| Drug | 4-oxoretinoic acid | 2.66e-04 | 115 | 25 | 3 | ctd:C002202 | |
| Drug | beta-damascenone | 3.15e-04 | 24 | 25 | 2 | ctd:C075388 | |
| Drug | adenosine 3',5'-cyclic phosphate | 3.63e-04 | 907 | 25 | 6 | CID000000274 | |
| Drug | o-phenylenediamine | 4.00e-04 | 27 | 25 | 2 | CID000007243 | |
| Drug | AC1L9H5I | 4.00e-04 | 27 | 25 | 2 | CID000444945 | |
| Drug | [(2R,3R,4R,5S,6R)-2-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-5-hydroxy-6-(hydroxymethyl)-3-[(2-tritioacetyl)amino]oxan-4-yl] (3R)-3-hydroxydecanoate | 4.30e-04 | 28 | 25 | 2 | CID011650719 | |
| Drug | CH2Cl | 4.30e-04 | 28 | 25 | 2 | CID005378701 | |
| Drug | AC1NQZM2 | 4.61e-04 | 29 | 25 | 2 | CID005282177 | |
| Drug | DMBA | 4.74e-04 | 140 | 25 | 3 | CID000006001 | |
| Drug | GW0742 | 5.28e-04 | 31 | 25 | 2 | ctd:C479979 | |
| Drug | CD367 | 5.99e-04 | 33 | 25 | 2 | CID000119342 | |
| Drug | EMCs | 6.36e-04 | 34 | 25 | 2 | CID005091655 | |
| Drug | d(GpG | 6.74e-04 | 35 | 25 | 2 | CID000161113 | |
| Drug | oxaliplatin | 7.25e-04 | 162 | 25 | 3 | CID000004609 | |
| Drug | Parthenolide [20554-84-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 7.38e-04 | 163 | 25 | 3 | 2885_DN | |
| Drug | chrysarobin | 7.53e-04 | 37 | 25 | 2 | CID000068111 | |
| Drug | A-K-V | 7.53e-04 | 37 | 25 | 2 | CID011840919 | |
| Drug | I5B1 | 7.53e-04 | 37 | 25 | 2 | CID005487705 | |
| Drug | 9,10-Dimethyl-1,2-benzanthracene | 7.73e-04 | 1046 | 25 | 6 | ctd:D015127 | |
| Drug | BW-B 70C; Up 200; 31.6uM; MCF7; HT_HG-U133A_EA | 8.19e-04 | 169 | 25 | 3 | 1132_UP | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; HL60; HT_HG-U133A | 8.48e-04 | 171 | 25 | 3 | 2723_UP | |
| Drug | tobacco tar | 8.92e-04 | 174 | 25 | 3 | ctd:C024746 | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 9.06e-04 | 175 | 25 | 3 | 1058_DN | |
| Drug | cerous chloride | 9.37e-04 | 177 | 25 | 3 | ctd:C026690 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 9.52e-04 | 178 | 25 | 3 | 3998_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 9.68e-04 | 179 | 25 | 3 | 4585_DN | |
| Drug | PM 2 | 9.70e-04 | 42 | 25 | 2 | CID000657077 | |
| Drug | AC1L9MBG | 9.70e-04 | 42 | 25 | 2 | CID000448761 | |
| Drug | Roxarsone | 9.70e-04 | 42 | 25 | 2 | ctd:D012406 | |
| Drug | Chrysin [480-40-0]; Down 200; 15.8uM; HL60; HT_HG-U133A | 9.99e-04 | 181 | 25 | 3 | 3106_DN | |
| Drug | A805480 | 1.06e-03 | 44 | 25 | 2 | CID000620368 | |
| Drug | 2,4-diacetylphloroglucinol | 1.06e-03 | 44 | 25 | 2 | CID000016547 | |
| Drug | ganglioside GD2 | 1.06e-03 | 44 | 25 | 2 | CID006450346 | |
| Drug | N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester | 1.06e-03 | 44 | 25 | 2 | ctd:C419410 | |
| Drug | Withaferin A [5119-48-2]; Down 200; 1uM; MCF7; HT_HG-U133A | 1.08e-03 | 186 | 25 | 3 | 3902_DN | |
| Drug | 5182598; Down 200; 25uM; MCF7; HT_HG-U133A_EA | 1.10e-03 | 187 | 25 | 3 | 868_DN | |
| Disease | Keratoderma, Palmoplantar | 2.99e-07 | 16 | 25 | 3 | C4551675 | |
| Disease | Epidermolytic ichthyosis | 6.89e-07 | 2 | 25 | 2 | cv:C0079153 | |
| Disease | Erythrokeratoderma, Reticular | 6.89e-07 | 2 | 25 | 2 | C1836681 | |
| Disease | Annular epidermolytic ichthyosis | 6.89e-07 | 2 | 25 | 2 | cv:C1843463 | |
| Disease | Congenital reticular ichthyosiform erythroderma | 6.89e-07 | 2 | 25 | 2 | C3665704 | |
| Disease | Keratosis of Greither | 6.89e-07 | 2 | 25 | 2 | C2936837 | |
| Disease | Ichthyosis, Cyclic, with Epidermolytic Hyperkeratosis | 6.89e-07 | 2 | 25 | 2 | C1843463 | |
| Disease | epidermolytic hyperkeratosis (is_implicated_in) | 6.89e-07 | 2 | 25 | 2 | DOID:4603 (is_implicated_in) | |
| Disease | Palmoplantar keratoderma, epidermolytic | 6.89e-07 | 2 | 25 | 2 | cv:C1721006 | |
| Disease | Keratoderma, Palmoplantar, Epidermolytic | 2.07e-06 | 3 | 25 | 2 | C1721006 | |
| Disease | HOLOPROSENCEPHALY 5 | 2.07e-06 | 3 | 25 | 2 | C1864827 | |
| Disease | Epidermolytic palmoplantar keratoderma Vorner type | 2.07e-06 | 3 | 25 | 2 | C2931735 | |
| Disease | epidermolytic hyperkeratosis (implicated_via_orthology) | 2.07e-06 | 3 | 25 | 2 | DOID:4603 (implicated_via_orthology) | |
| Disease | Epidermolytic palmoplantar keratoderma of Vorner | 2.07e-06 | 3 | 25 | 2 | C0343110 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 6.53e-06 | 145 | 25 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | Hyperkeratosis, Epidermolytic | 6.88e-06 | 5 | 25 | 2 | C0079153 | |
| Disease | holoprosencephaly (is_implicated_in) | 1.92e-05 | 8 | 25 | 2 | DOID:4621 (is_implicated_in) | |
| Disease | Holoprosencephaly sequence | 3.09e-05 | 10 | 25 | 2 | cv:C0079541 | |
| Disease | Alobar Holoprosencephaly | 7.19e-05 | 15 | 25 | 2 | C0431363 | |
| Disease | Lobar Holoprosencephaly | 8.21e-05 | 16 | 25 | 2 | C0431362 | |
| Disease | Semilobar Holoprosencephaly | 8.21e-05 | 16 | 25 | 2 | C0751617 | |
| Disease | Holoprosencephaly | 9.30e-05 | 17 | 25 | 2 | C0079541 | |
| Disease | Anophthalmia-microphthalmia syndrome | 1.43e-04 | 21 | 25 | 2 | cv:C5680330 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 3.87e-04 | 169 | 25 | 3 | DOID:3908 (is_marker_for) | |
| Disease | insulin sensitivity measurement, glucose homeostasis measurement | 6.09e-04 | 43 | 25 | 2 | EFO_0004471, EFO_0006896 | |
| Disease | Malignant neoplasm of salivary gland | 6.67e-04 | 45 | 25 | 2 | C0220636 | |
| Disease | Salivary Gland Neoplasms | 7.28e-04 | 47 | 25 | 2 | C0036095 | |
| Disease | myopathy (implicated_via_orthology) | 7.59e-04 | 48 | 25 | 2 | DOID:423 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSGGGGGSSGNGGGG | 81 | Q9UI36 | |
| GGFGGSCGGGGYGGS | 226 | Q32P51 | |
| GGGRGGGSFGGGYGG | 461 | P13645 | |
| GGSFGGGYGGGSSGG | 466 | P13645 | |
| GHGGGHGGSSGGGYG | 486 | P13645 | |
| GGGSSGGGGGGYGGG | 531 | P13645 | |
| GGGGGGYGGGSSGGG | 536 | P13645 | |
| GGGSGGGFGGGYGSG | 116 | P35527 | |
| GGSGGSYGGGGSGGG | 491 | P35527 | |
| GGGSGSGGGSGGGYG | 521 | P35527 | |
| SGGGSGGGYGGGSGG | 526 | P35527 | |
| GGGYGGGSGGGHSGG | 531 | P35527 | |
| GSGSGGGSGGGYGGG | 561 | P35527 | |
| GGGGGGGNGAGGGSS | 201 | Q9NXD2 | |
| SSGSAGGGGGGGGGG | 11 | Q96AE4 | |
| AGGGAGGGGAGGGGS | 16 | Q01167 | |
| GGGGGGGGGGNYGQD | 166 | P35637 | |
| GYGGGGSGGGGRGGF | 396 | P35637 | |
| GGGLGGGYGGGLGGG | 66 | P13646 | |
| GGGGSGAGGGSGGSG | 21 | Q6PID8 | |
| GGSYGSGGGGGGGRG | 536 | P04264 | |
| GGGGFGGGSLSGGGG | 26 | P19012 | |
| GGGGGGGGGSSGYGS | 701 | Q12906 | |
| GDPYGGGGGGGGGGG | 411 | Q52LJ0 | |
| GGGGSSGGGGGGGAY | 771 | Q10571 | |
| GSGGGGAGTGGGAGG | 426 | P84550 | |
| SGGGGHGGGGGGGSS | 161 | Q06945 | |
| NGAGGGGGAGGGSGG | 36 | O95343 | |
| GGGAGGGSGGGNGAG | 41 | O95343 | |
| GGSGGGNGAGGGGAG | 46 | O95343 | |
| GSGGGGSGGGRGAGG | 21 | Q9UHB9 | |
| GSGGGGGGGGGGSSA | 136 | Q8IXZ3 | |
| FGGGGGGCSSGGGGG | 921 | Q9UM73 | |
| GYGGGRGGYGGGGPG | 261 | P22626 | |
| GAGGGGGGSSGGGSG | 501 | O95409 | |
| GGGGGGGGGGGGSYH | 3516 | Q15911 | |
| GGAAGGYGGAGGGGS | 361 | Q00653 |